Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.6992
-0.0001 (-0.01%)
At close: Jul 25, 2025, 4:00 PM
0.6800
-0.0192 (-2.75%)
After-hours: Jul 25, 2025, 4:00 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.46 million as of July 25, 2025. Its market cap has increased by 192.43% in one year.
Market Cap
4.46M
Enterprise Value
-5.26M
1-Year Change
192.43%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.46M, a decrease of -92.24%. That is a compound annual growth rate of -47.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 4.46M | 61.87% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |